Research Article

GLP-1 Gene-Modified Human Umbilical Cord Mesenchymal Stem Cell Line Improves Blood Glucose Level in Type 2 Diabetic Mice

Figure 2

Release of GLP-1 by modified mesenchymal stems cells in type 2 diabetic mice. (a) GLP-1 content in mouse serum within 168 hours after single intramuscular injection of modified mesenchymal stem cells. (b) Cumulative food intake 24 hours after a single intramuscular injection. (c) Effects on food intake at different times after intramuscular injection. (d) The effect of different times on body weight. (e) Weight gain ratio at 3 weeks of administration. Data are (). c, d, compared with Ad-GFP-hUC-MSC control mice.
(a)
(b)
(c)
(d)
(e)